FDA has approved a new, under-the-skin levodopa/carbidopa infusion for people with progressing Parkinson’s. In clinical trials, the medication led to increased total daily “on” time, when symptoms are well-controlled, compared to oral levodopa/carbidopa pills.
–
Visit the “Learn More” Here: 
–
–
–